openPR Logo
Press release

OTC Analgesics Market Progress & Manufacturer Contribution Highlighted until 2022 | Major Players - Sun Pharmaceuticals Industries Limited, Johnson & Johnson Service, AstraZeneca Plc., Reckitt Benckiser Group Plc., Novartis AG

06-11-2019 02:36 PM CET | Health & Medicine

Press release from: Fact.MR

OTC Analgesics Market Progress & Manufacturer Contribution

Analgesics are counter pain drugs, which stop the pain sensation for some time, or completely eliminate the feeling of pain. These drugs are often consumed by individuals, without the need for any necessary prescription, for type of pain which reoccurs or is of less degree. The drugs which don’t require prescription fall under OTC analgesics, for example drugs for reducing fever, or body pain killers.

Request Free Sample Report Here: https://www.factmr.com/connectus/sample?flag=S&rep_id=75

The advent of healthcare reforms, and favorable regulatory norms worldwide, have encouraged the initiation & uptake of several pain management programs, in a bid to reduce the overall healthcare costs. For example, Patient Protection and Affordable Care Act of the U.S. has provisions for pain management. These instances have paved ways for developing effective OTC analgesics. OTC analgesic drugs are usually purchased in large quantities, with wide availability of drugs for relieving various types of pain in distribution stores. These factors are expected to influence growth of the global OTC analgesics market.

The trend of utilizing off-label drugs, which are unapproved and affordable medications effective for treatment of diseases, has been gaining an uptick over the recent past. Management of symptoms related to pain has become easy and convenient owing to the availability of OTC analgesics, and these are further prescribed with approved drugs as the maintenance therapies. There is a high potential for growth of the global OTC analgesics market, with sales and demand for pain medication such as pain killers, or pain relievers gaining a significant prevalence among individuals. In addition, demand for non-narcotic pain medication has been witnessing a surge on the back of ill effects associated with narcotic drugs on patients. Topical analgesic manufacturers as well as distributor are increasing their product portfolio to gain huge profits from opportunities in the developed as well as developing markets.

The global OTC analgesics market is projected to register a steady expansion through 2022. The market is estimated to surpass revenues worth US$ 20,000 Mn by 2022 end.

View Full Report with Table of Content: https://www.factmr.com/report/75/otc-analgesics-market

Pharmacy to Remain the Most Lucrative OTC Channel in the Global OTC Analgesics Market

Pharmacy will remain the most lucrative OTC channel for sales of OTC analgesics in the market. Drug store is expected to be the second largest OTC channel in the market. OTC analgesics sales in online store, and the modern trade OTC channels will register the fastest expansion through 2022.

North America will continue to account for the largest revenue share of the market, and is estimated to retain its dominance in the global OTC analgesics market over the forecast period. In addition, Europe will remain the second most lucrative market for OTC analgesics, however the market in Japan will register a relatively faster expansion than in Europe through 2022.

OTC analgesics in the form of tablets will account for more than half revenue share of the market over the forecast period. In addition, tablet OTC analgesics are anticipated to remain sought-after among consumers around the world. Capsule will continue to be the second largest sold OTC analgesics product in the global market, with sales expanding at the highest CAGR throughout the forecast period.

Competition Tracking

Key market players mentioned in Fact.MR’s report include Sun Pharmaceuticals Industries Limited, Johnson & Johnson Service, Inc., AstraZeneca Plc., Reckitt Benckiser Group Plc., Novartis AG, GlaxoSmithKline Plc., and Pfizer Inc.

Have Any Query? Discuss with Our Expert Team @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=75

Contact Us            
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://www.industrynewsanalysis.com/

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release OTC Analgesics Market Progress & Manufacturer Contribution Highlighted until 2022 | Major Players - Sun Pharmaceuticals Industries Limited, Johnson & Johnson Service, AstraZeneca Plc., Reckitt Benckiser Group Plc., Novartis AG here

News-ID: 1771513 • Views:

More Releases from Fact.MR

Rechargeable Camping Gear Market Set to Surge, Forecasted to Reach US$ 5,362.7 Million by 2033
Rechargeable Camping Gear Market Set to Surge, Forecasted to Reach US$ 5,362.7 M …
The rechargeable camping gear market was valued at US$ 1,827.6 million in 2022 and is expected to grow at a CAGR of 10.5% over the forecast period, reaching US$ 5,362.7 million in 2033. Rechargeable camping gear offers more than just power solutions; it incorporates additional features to enhance the camping experience. With built-in USB ports, campers can conveniently charge their electronic devices. These versatile gear options also provide multiple lighting modes,
Motor Driver ICs is projected to reach US$ 1.58 billion by 2034
Motor Driver ICs is projected to reach US$ 1.58 billion by 2034
The global motor driver IC market is poised to reach US$ 831.8 million in 2024. Over the assessment period (2024 to 2034), worldwide demand for motor driver integrated circuits is projected to exhibit a 6.6% CAGR (compound annual growth rate), resulting in a market size of US$ 1.58 billion by the end of 2034. Increasing automation of industrial procedures along with the increasing use of robots in numerous sectors, such as
Consumer Data Storage Device Market is forecasted to expand at 3.4% CAGR from 2024 to 2034
Consumer Data Storage Device Market is forecasted to expand at 3.4% CAGR from 20 …
Fact.MR, a market research and competitive intelligence provider, in its newly published research report, reveals that the global Consumer Data Storage Device Market is calculated at US$ 17.57 billion for 2024 and is forecasted to increase at a CAGR of 3.4% from 2024 to 2034. Expansion of the global market is attributed to several factors, including the growing adoption of machine learning (ML), artificial intelligence (AI), analytics, and cloud-based services across
Sales of Sports Supplements are forecasted to reach US$ 27.89 billion by 2034
04-16-2024 | Sports
Fact.MR
Sales of Sports Supplements are forecasted to reach US$ 27.89 billion by 2034
As per a new industry analysis by Fact.MR, a market research and competitive intelligence provider, the global Sports Supplement Market is exhibiting substantial growth and is projected to advance at a CAGR of 12.1% and reach a size of US$ 27.89 billion by 2034-end. This rise is being driven by growing fitness awareness and an increasing number of health-conscious consumers. Protein powders, energy bars, and nutritional supplements targeting particular fitness objectives

All 5 Releases


More Releases for OTC

Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to
Investigation for Long-Term Investors in shares of Volkswagen AG (OTC: VWAGY / O …
An investigation on behalf of current long-term investors in shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) was announced over potential breaches of fiduciary duties by certain officers and directors at Volkswagen AG. Investors who purchased shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) and currently hold any of those Volkswagen AG shares have certain options and should contact the Shareholders Foundation at
OTC: VWAGY / OTC: VLKAF / OTC: VWAPY Shareholder Notice: Update in Lawsuit again …
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Volkswagen AG (OTC: VWAGY) (OTC: VWAPY) shares. Investors, who purchased shares of Volkswagen AG (OTC: VWAGY) (OTC: VLKAF) (OTC: VWAPY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On September 25, 2015, a lawsuit was filed against Volkswagen AG (alleged securities laws violations. The plaintiff claimed that the defendants
OTC Analgesics Market OTC analgesics market is projected to register a steady ex …
About OTC Analgesics Market The global OTC analgesics market is projected to register an above-average CAGR during 2017 to 2022. Global sales of OTC analgesics is estimated to account for nearly US$ 25,000 Mn revenues by 2022-end. Get Sample copy of this Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=75 The trend of using off-label drugs that are affordable and unapproved, but effective in treating diseases, has been witnessing an upsurge over the past few years.
03-14-2018 | Health & Medicine
Fact.MR
OTC Analgesics Market Report 2017-22: Pharmacy to Remain the Most Lucrative OTC …
A fresh study, covering “OTC Analgesics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make
The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects
ReportsWeb.com has announced the addition of the “Global OTC Drugs Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. GBI Research's latest report, "The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current